Thermo Fisher Scientific provides notice to holders of Apogent Technologies' convertible senior debentures

As required under the indenture covering Apogent Technologies Inc. Floating Rate Convertible Senior Debentures due 2033 (CUSIP No. 03760AAK7), Thermo Fisher Scientific Inc. (NYSE: TMO) is providing public notice to the holders of these bonds that they have the right to convert the debentures and to receive a contingent interest payment.

The debentures are convertible because Thermo Fisher stock traded above the minimum price specified in the indenture over the applicable measurement period. The debentures continue to be convertible until July 3, 2010, and may be convertible thereafter, depending on whether or not one of the conversion conditions specified in the indenture is satisfied during future measurement periods. If conversion requests are received, Thermo Fisher has the right to decide if settlement of the debentures will be paid in cash, or a combination of cash and shares of its common stock.

The contingent interest, for the current quarterly interest period ending June 15, 2010, is payable because the average trading price of these debentures was equal to 120% or more of the principal amount of the debentures for the relevant measurement period. The amount of contingent interest payable for the period is equal to 0.0625% of the average trading price of the debentures over the measurement period triggering the contingent interest payment. The contingent interest payout amount per 1,000 of principal is $1.0453.

Thermo Fisher Scientific assumed the Apogent Technologies debentures as part of its acquisition of Fisher Scientific International Inc. ("Fisher") in 2006. Fisher acquired Apogent in 2004. The Bank of New York Mellon is the trustee for the debentures.

SOURCE Thermo Fisher Scientific Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 20). Thermo Fisher Scientific provides notice to holders of Apogent Technologies' convertible senior debentures. News-Medical. Retrieved on May 29, 2024 from https://www.news-medical.net/news/20100413/Thermo-Fisher-Scientific-provides-notice-to-holders-of-Apogent-Technologies-convertible-senior-debentures.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific provides notice to holders of Apogent Technologies' convertible senior debentures". News-Medical. 29 May 2024. <https://www.news-medical.net/news/20100413/Thermo-Fisher-Scientific-provides-notice-to-holders-of-Apogent-Technologies-convertible-senior-debentures.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific provides notice to holders of Apogent Technologies' convertible senior debentures". News-Medical. https://www.news-medical.net/news/20100413/Thermo-Fisher-Scientific-provides-notice-to-holders-of-Apogent-Technologies-convertible-senior-debentures.aspx. (accessed May 29, 2024).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Fisher Scientific provides notice to holders of Apogent Technologies' convertible senior debentures. News-Medical, viewed 29 May 2024, https://www.news-medical.net/news/20100413/Thermo-Fisher-Scientific-provides-notice-to-holders-of-Apogent-Technologies-convertible-senior-debentures.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Thermo Fisher Scientific expands deployment model options for SampleManager LIMS software